BETWEEN MEDISAFE 1 TECHNOLOGIES CORP., AS LICENSOR AND SAFECODE DRUG TECHNOLOGIES CORP., AS Licensee Dated: November 15, 2012 LICENSE AGREEMENTLicense Agreement • November 20th, 2012 • Safecode Drug Technologies Corp. • Surgical & medical instruments & apparatus • New York
This License Agreement, dated this 15 day of November, 2012 (the "License Agreement"), is by and between Medisafe 1 Technologies Corp., a Delaware corporation having its principal office at 5a Hataltan Street, Jerusalem 96926, Israel (hereinafter, the "Licensor”) and Safecode Drug Technologies Corp., a Delaware corporation having its principal office at 6 Meever HaMiltah Street, Jerusalem 97761, Israel (hereinafter, the "Licensee”). The Licensor and Licensee are sometimes referred to individually, as a "Party" and collectively, as the "Parties."
SAFECODE DRUG TECHNOLOGIES CORP Subscription AgreementSubscription Agreement • November 29th, 2011 • Safecode Drug Technologies Corp. • Surgical & medical instruments & apparatus
The undersigned investor in this Subscription Agreement hereby acknowledges receipt of the prospectus, dated __________________, 2011, of SAFECODE DRUG TECHNOLOGIES CORP a Delaware Corporation, (the "Prospectus" and the “Company”), and subscribes for the following number of shares upon the terms and conditions set forth in the Prospectus.
ContractPatent Agreement • December 21st, 2011 • Safecode Drug Technologies Corp. • Surgical & medical instruments & apparatus
Re: Service Agreement: Assistance in Development of prototype for submission to US Department of Defense Dear Sir; Our offer covers the following issues:Service Agreement • July 31st, 2012 • Safecode Drug Technologies Corp. • Surgical & medical instruments & apparatus
